| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |